HEADER ANTIBIOTIC 29-OCT-18 6MW0
TITLE MLE-PHE-MLE-D-PHE. LINEAR TETRAPEPTIDE RELATED TO PSEUDOXYLALLEMYCIN
TITLE 2 A.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MLE-PHE-MLE-D-PHE LINEAR TETRAPEPTIDE RELATED TO
COMPND 3 PSEUDOXYLALLEMYCIN A;
COMPND 4 CHAIN: A;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 ORGANISM_SCIENTIFIC: XYLARIA;
SOURCE 4 ORGANISM_TAXID: 37991
KEYWDS TETRAPEPTIDE, N-METHYL LEUCINE, PSEUDOXYLALLEMYCIN A, ANTIBIOTIC
EXPDTA X-RAY DIFFRACTION
AUTHOR A.J.CAMERON,P.W.R.HARRIS,M.A.BRIMBLE,C.J.SQUIRE
REVDAT 2 23-OCT-24 6MW0 1 REMARK
REVDAT 1 11-SEP-19 6MW0 0
JRNL AUTH A.J.CAMERON,C.J.SQUIRE,A.GERENTON,L.A.STUBBING,P.W.R.HARRIS,
JRNL AUTH 2 M.A.BRIMBLE
JRNL TITL INVESTIGATIONS OF THE KEY MACROLACTAMISATION STEP IN THE
JRNL TITL 2 SYNTHESIS OF CYCLIC TETRAPEPTIDE PSEUDOXYLALLEMYCIN A.
JRNL REF ORG.BIOMOL.CHEM. V. 17 3902 2019
JRNL REFN ESSN 1477-0539
JRNL PMID 30941386
JRNL DOI 10.1039/C9OB00227H
REMARK 2
REMARK 2 RESOLUTION. 0.78 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : SHELXL
REMARK 3 AUTHORS : G.M.SHELDRICK
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.78
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.02
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 3 CROSS-VALIDATION METHOD : NONE
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF).
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).
REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL
REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 41
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 2
REMARK 3 SOLVENT ATOMS : 7
REMARK 3
REMARK 3 MODEL REFINEMENT.
REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL
REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL
REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL
REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL
REMARK 3 NUMBER OF RESTRAINTS : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.
REMARK 3 BOND LENGTHS (A) : NULL
REMARK 3 ANGLE DISTANCES (A) : NULL
REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL
REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL
REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL
REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL
REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL
REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL
REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL
REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED: NULL
REMARK 3
REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL
REMARK 3 SPECIAL CASE: NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: FULL LEAST SQUARES REFINEMENT IN SHELXL
REMARK 3 WITH ANISOTROPIC DISPLACEMENT PARAMETERS AND HYDROGENS PLACED IN
REMARK 3 RIDING POSITIONS.
REMARK 4
REMARK 4 6MW0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-18.
REMARK 100 THE DEPOSITION ID IS D_1000237717.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 13-JUL-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON
REMARK 200 BEAMLINE : MX2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.71075
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4911
REMARK 200 RESOLUTION RANGE HIGH (A) : 0.780
REMARK 200 RESOLUTION RANGE LOW (A) : 23.020
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2
REMARK 200 DATA REDUNDANCY : 11.50
REMARK 200 R MERGE (I) : 0.05900
REMARK 200 R SYM (I) : NULL
REMARK 200 FOR THE DATA SET : 14.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.78
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.80
REMARK 200 COMPLETENESS FOR SHELL (%) : 92.0
REMARK 200 DATA REDUNDANCY IN SHELL : 10.00
REMARK 200 R MERGE FOR SHELL (I) : 0.56700
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 FOR SHELL : 2.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING
REMARK 200 SOFTWARE USED: SHELXS
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 30.19
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.76
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: METHANOL, WATER, EVAPORATION,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 4.14550
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 11.50800
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 10.46550
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 11.50800
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 4.14550
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 10.46550
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 70 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 830 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 MLE-PHE-MLE-D-PHE. LINEAR TETRAPEPTIDE RELATED TO
REMARK 400 PSEUDOXYLALLEMYCIN A. THIS PEPTIDE IS LINEAR, UNLIKE CYCLIC
REMARK 400 PSEUDOXYLALLEMYCIN A, AND CONTAINS TERMINAL D-PHE, UNLIKE
REMARK 400 PSEUDOXYLALLEMYCIN A THAT CONTAINS PHE.
REMARK 400
REMARK 400 THE LINEAR TETRAPEPTIDE RELATED TO PSEUDOXYLALLEMYCIN A IS PEPTIDE-
REMARK 400 LIKE, A MEMBER OF ANTIBIOTIC CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: LINEAR TETRAPEPTIDE RELATED TO PSEUDOXYLALLEMYCIN A
REMARK 400 CHAIN: A
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6MVZ RELATED DB: PDB
REMARK 900 ALL L- VERSION OF THIS PEPTIDE
DBREF 6MW0 A 1001 1004 PDB 6MW0 6MW0 1001 1004
SEQRES 1 A 4 MLE PHE MLE DPN
HET MLE A1001 18
HET MLE A1003 18
HET DPN A1004 24
HET MOH A1101 2
HETNAM MLE N-METHYLLEUCINE
HETNAM DPN D-PHENYLALANINE
HETNAM MOH METHANOL
FORMUL 1 MLE 2(C7 H15 N O2)
FORMUL 1 DPN C9 H11 N O2
FORMUL 2 MOH C H4 O
FORMUL 3 HOH *7(H2 O)
LINK C AMLE A1001 N APHE A1002 1555 1555 1.37
LINK C BMLE A1001 N BPHE A1002 1555 1555 1.34
LINK C APHE A1002 N AMLE A1003 1555 1555 1.35
LINK C BPHE A1002 N BMLE A1003 1555 1555 1.34
LINK C AMLE A1003 N ADPN A1004 1555 1555 1.30
LINK C BMLE A1003 N BDPN A1004 1555 1555 1.31
CRYST1 8.291 20.931 23.016 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.120613 0.000000 0.000000 0.00000
SCALE2 0.000000 0.047776 0.000000 0.00000
SCALE3 0.000000 0.000000 0.043448 0.00000
HETATM 1 N AMLE A1001 11.602 8.455 16.491 0.50 4.13 N
ANISOU 1 N AMLE A1001 436 429 613 -5 -30 -109 N
HETATM 2 N BMLE A1001 11.466 8.479 16.214 0.50 5.89 N
ANISOU 2 N BMLE A1001 489 517 1099 27 -138 70 N
HETATM 3 CN AMLE A1001 11.460 8.818 15.113 0.50 5.71 C
ANISOU 3 CN AMLE A1001 749 569 723 -96 62 55 C
HETATM 4 CN BMLE A1001 11.343 8.862 14.809 0.50 6.13 C
ANISOU 4 CN BMLE A1001 638 679 875 3 -110 -145 C
HETATM 5 CA AMLE A1001 10.306 8.231 17.200 0.50 4.98 C
ANISOU 5 CA AMLE A1001 506 588 688 1 31 -150 C
HETATM 6 CA BMLE A1001 10.225 8.290 17.023 0.50 5.15 C
ANISOU 6 CA BMLE A1001 415 483 942 21 -126 70 C
HETATM 7 CB AMLE A1001 10.553 7.749 18.628 0.50 5.85 C
ANISOU 7 CB AMLE A1001 725 687 680 227 -54 -104 C
HETATM 8 CB BMLE A1001 10.557 7.896 18.466 0.50 6.10 C
ANISOU 8 CB BMLE A1001 355 688 1137 96 -53 291 C
HETATM 9 CG AMLE A1001 9.296 7.088 19.172 0.50 7.71 C
ANISOU 9 CG AMLE A1001 518 1413 823 384 6 65 C
HETATM 10 CG BMLE A1001 9.386 7.670 19.495 0.50 6.48 C
ANISOU 10 CG BMLE A1001 742 858 715 94 -2 -149 C
HETATM 11 CD1AMLE A1001 9.446 6.971 20.701 0.50 10.07 C
ANISOU 11 CD1AMLE A1001 927 1751 920 802 27 325 C
HETATM 12 CD1BMLE A1001 9.922 7.351 20.868 0.50 9.68 C
ANISOU 12 CD1BMLE A1001 633 1888 938 -17 18 182 C
HETATM 13 CD2AMLE A1001 9.106 5.643 18.622 0.50 9.48 C
ANISOU 13 CD2AMLE A1001 746 1193 1448 -218 9 402 C
HETATM 14 CD2BMLE A1001 8.496 6.561 18.922 0.50 8.50 C
ANISOU 14 CD2BMLE A1001 652 1275 1112 -238 103 258 C
HETATM 15 C AMLE A1001 9.567 9.571 17.083 0.50 5.21 C
ANISOU 15 C AMLE A1001 304 652 907 -20 -23 -2 C
HETATM 16 C BMLE A1001 9.459 9.627 17.073 0.50 5.17 C
ANISOU 16 C BMLE A1001 591 486 769 107 -183 -13 C
HETATM 17 O AMLE A1001 10.234 10.633 17.344 0.50 5.59 O
ANISOU 17 O AMLE A1001 326 509 1162 8 66 -88 O
HETATM 18 O BMLE A1001 9.967 10.609 17.548 0.50 5.99 O
ANISOU 18 O BMLE A1001 312 630 1199 99 -192 -147 O
ATOM 19 N APHE A1002 8.249 9.627 16.719 0.50 4.20 N
ANISOU 19 N APHE A1002 350 733 416 -20 14 -61 N
ATOM 20 N BPHE A1002 8.236 9.497 16.542 0.50 6.13 N
ANISOU 20 N BPHE A1002 425 576 1189 101 -27 -85 N
ATOM 21 CA APHE A1002 7.482 10.940 16.586 0.50 4.84 C
ANISOU 21 CA APHE A1002 392 454 884 -67 -78 13 C
ATOM 22 CA BPHE A1002 7.347 10.603 16.472 0.50 4.44 C
ANISOU 22 CA BPHE A1002 369 397 821 -72 5 89 C
ATOM 23 C APHE A1002 6.395 10.745 17.569 0.50 4.97 C
ANISOU 23 C APHE A1002 337 576 865 -88 -86 -8 C
ATOM 24 C BPHE A1002 6.185 10.596 17.551 0.50 4.16 C
ANISOU 24 C BPHE A1002 241 503 741 -26 39 72 C
ATOM 25 O APHE A1002 5.567 9.732 17.487 0.50 4.38 O
ANISOU 25 O APHE A1002 257 543 766 38 13 11 O
ATOM 26 O BPHE A1002 5.258 9.842 17.312 0.50 6.45 O
ANISOU 26 O BPHE A1002 299 848 1159 0 -13 -207 O
ATOM 27 CB APHE A1002 6.791 11.167 15.251 0.50 5.73 C
ANISOU 27 CB APHE A1002 494 591 963 87 29 84 C
ATOM 28 CB BPHE A1002 6.807 10.546 15.052 0.50 5.80 C
ANISOU 28 CB BPHE A1002 536 793 745 30 -46 86 C
ATOM 29 CG APHE A1002 7.780 11.410 14.122 0.70 8.26 C
ANISOU 29 CG APHE A1002 590 1469 894 62 -93 400 C
ATOM 30 CG BPHE A1002 7.867 10.461 13.964 0.30 4.71 C
ANISOU 30 CG BPHE A1002 505 631 545 -4 -114 170 C
ATOM 31 CD1APHE A1002 8.348 10.387 13.390 0.70 10.86 C
ANISOU 31 CD1APHE A1002 631 2298 952 382 64 106 C
ATOM 32 CD1BPHE A1002 8.222 9.286 13.333 0.30 5.42 C
ANISOU 32 CD1BPHE A1002 638 721 578 29 -26 42 C
ATOM 33 CD2APHE A1002 8.122 12.713 13.821 0.70 11.72 C
ANISOU 33 CD2APHE A1002 1207 1768 1213 -706 -377 632 C
ATOM 34 CD2BPHE A1002 8.503 11.629 13.595 0.30 6.83 C
ANISOU 34 CD2BPHE A1002 978 782 681 -253 -135 249 C
ATOM 35 CE1APHE A1002 9.244 10.637 12.370 0.70 14.74 C
ANISOU 35 CE1APHE A1002 941 3426 901 285 7 347 C
ATOM 36 CE1BPHE A1002 9.194 9.284 12.354 0.30 6.02 C
ANISOU 36 CE1BPHE A1002 589 1079 483 55 -63 -74 C
ATOM 37 CE2APHE A1002 9.017 12.970 12.802 0.70 15.29 C
ANISOU 37 CE2APHE A1002 1217 2944 1301 -958 -472 832 C
ATOM 38 CE2BPHE A1002 9.475 11.629 12.615 0.30 7.46 C
ANISOU 38 CE2BPHE A1002 832 1007 825 -502 -141 373 C
ATOM 39 CZ APHE A1002 9.581 11.942 12.074 0.70 16.62 C
ANISOU 39 CZ APHE A1002 899 3930 1112 -469 -180 848 C
ATOM 40 CZ BPHE A1002 9.828 10.453 11.986 0.30 8.34 C
ANISOU 40 CZ BPHE A1002 905 1655 420 -384 -20 -30 C
HETATM 41 N AMLE A1003 6.196 11.597 18.592 0.50 5.43 N
ANISOU 41 N AMLE A1003 505 811 625 -202 -114 45 N
HETATM 42 N BMLE A1003 6.303 11.400 18.615 0.50 6.59 N
ANISOU 42 N BMLE A1003 684 745 928 -251 146 -25 N
HETATM 43 CN AMLE A1003 7.065 12.795 18.821 0.50 6.35 C
ANISOU 43 CN AMLE A1003 446 694 1130 -68 115 -263 C
HETATM 44 CN BMLE A1003 7.474 12.284 18.830 0.50 6.14 C
ANISOU 44 CN BMLE A1003 642 670 883 -171 123 -151 C
HETATM 45 CA AMLE A1003 5.051 11.288 19.547 0.50 6.24 C
ANISOU 45 CA AMLE A1003 826 663 742 -20 8 152 C
HETATM 46 CA BMLE A1003 5.238 11.412 19.643 0.50 5.50 C
ANISOU 46 CA BMLE A1003 485 725 755 -281 56 -198 C
HETATM 47 CB AMLE A1003 5.625 11.157 21.018 0.50 5.37 C
ANISOU 47 CB AMLE A1003 516 779 622 36 102 -138 C
HETATM 48 CB BMLE A1003 5.940 11.032 20.946 0.50 6.78 C
ANISOU 48 CB BMLE A1003 681 853 890 -74 28 32 C
HETATM 49 CG AMLE A1003 6.562 9.974 21.134 0.50 5.68 C
ANISOU 49 CG AMLE A1003 592 797 641 -100 -47 53 C
HETATM 50 CG BMLE A1003 6.653 9.738 21.167 0.50 7.14 C
ANISOU 50 CG BMLE A1003 871 752 928 52 244 -9 C
HETATM 51 CD1AMLE A1003 5.831 8.661 20.831 0.50 6.63 C
ANISOU 51 CD1AMLE A1003 745 756 868 -165 24 334 C
HETATM 52 CD1BMLE A1003 5.833 8.491 20.822 0.50 10.14 C
ANISOU 52 CD1BMLE A1003 950 694 1978 62 -357 78 C
HETATM 53 CD2AMLE A1003 7.154 9.917 22.545 0.50 7.69 C
ANISOU 53 CD2AMLE A1003 694 1399 653 211 -21 127 C
HETATM 54 CD2BMLE A1003 7.182 9.639 22.574 0.50 10.06 C
ANISOU 54 CD2BMLE A1003 1163 1274 1157 470 -187 -116 C
HETATM 55 C AMLE A1003 4.062 12.465 19.550 0.50 6.47 C
ANISOU 55 C AMLE A1003 787 662 861 -138 86 47 C
HETATM 56 C BMLE A1003 4.355 12.656 19.621 0.50 5.82 C
ANISOU 56 C BMLE A1003 615 761 705 -250 106 -79 C
HETATM 57 O AMLE A1003 3.333 12.566 20.420 0.50 8.16 O
ANISOU 57 O AMLE A1003 1361 966 590 185 310 169 O
HETATM 58 O BMLE A1003 3.947 13.119 20.732 0.50 16.43 O
ANISOU 58 O BMLE A1003 2462 2624 786 1553 -127 -484 O
HETATM 59 N ADPN A1004 4.155 13.249 18.516 0.50 6.98 N
ANISOU 59 N ADPN A1004 1218 385 890 -37 278 80 N
HETATM 60 N BDPN A1004 4.014 13.232 18.496 0.50 8.08 N
ANISOU 60 N BDPN A1004 1413 678 795 92 143 -166 N
HETATM 61 CA ADPN A1004 3.235 14.461 18.421 0.50 8.16 C
ANISOU 61 CA ADPN A1004 953 388 1573 -43 218 3 C
HETATM 62 CA BDPN A1004 3.224 14.382 18.316 0.50 6.50 C
ANISOU 62 CA BDPN A1004 1185 516 620 -49 398 -55 C
HETATM 63 C ADPN A1004 4.186 15.703 18.110 0.50 5.14 C
ANISOU 63 C ADPN A1004 971 396 470 35 134 -49 C
HETATM 64 C BDPN A1004 4.010 15.706 18.338 0.50 7.55 C
ANISOU 64 C BDPN A1004 890 752 1056 -209 167 -72 C
HETATM 65 O ADPN A1004 5.412 15.620 18.040 0.50 6.21 O
ANISOU 65 O ADPN A1004 727 564 927 -204 -296 115 O
HETATM 66 O BDPN A1004 5.229 15.544 18.355 0.50 11.74 O
ANISOU 66 O BDPN A1004 981 776 2437 -54 26 463 O
HETATM 67 OXTADPN A1004 3.544 16.753 18.063 0.50 5.88 O
ANISOU 67 OXTADPN A1004 947 377 776 -119 393 -60 O
HETATM 68 OXTBDPN A1004 3.438 16.795 18.346 0.50 13.31 O
ANISOU 68 OXTBDPN A1004 905 458 3393 -86 888 -406 O
HETATM 69 CB ADPN A1004 2.242 14.198 17.170 0.50 8.78 C
ANISOU 69 CB ADPN A1004 670 460 2006 102 156 7 C
HETATM 70 CB BDPN A1004 2.235 14.287 17.153 0.50 6.17 C
ANISOU 70 CB BDPN A1004 670 378 1157 -222 433 -171 C
HETATM 71 CG ADPN A1004 2.919 14.209 15.832 0.50 7.75 C
ANISOU 71 CG ADPN A1004 568 425 1775 46 -214 -43 C
HETATM 72 CG BDPN A1004 2.920 14.204 15.822 0.50 5.26 C
ANISOU 72 CG BDPN A1004 465 697 718 -110 -20 -131 C
HETATM 73 CD1ADPN A1004 3.135 15.372 15.120 0.50 8.02 C
ANISOU 73 CD1ADPN A1004 422 523 1919 -13 -179 24 C
HETATM 74 CD1BDPN A1004 3.149 15.347 15.083 0.50 6.01 C
ANISOU 74 CD1BDPN A1004 815 667 667 -90 -43 -152 C
HETATM 75 CD2ADPN A1004 3.350 13.022 15.274 0.50 8.27 C
ANISOU 75 CD2ADPN A1004 768 554 1634 227 -386 -181 C
HETATM 76 CD2BDPN A1004 3.345 13.006 15.282 0.50 5.43 C
ANISOU 76 CD2BDPN A1004 575 665 700 31 -121 -149 C
HETATM 77 CE1ADPN A1004 3.759 15.363 13.889 0.50 10.21 C
ANISOU 77 CE1ADPN A1004 748 821 2077 116 -34 218 C
HETATM 78 CE1BDPN A1004 3.777 15.301 13.855 0.50 6.19 C
ANISOU 78 CE1BDPN A1004 596 938 677 -204 -139 18 C
HETATM 79 CE2ADPN A1004 3.976 12.994 14.045 0.50 9.90 C
ANISOU 79 CE2ADPN A1004 953 880 1703 495 -273 -62 C
HETATM 80 CE2BDPN A1004 3.975 12.935 14.056 0.50 6.04 C
ANISOU 80 CE2BDPN A1004 756 878 524 146 -218 -113 C
HETATM 81 CZ ADPN A1004 4.183 14.167 13.347 0.50 10.41 C
ANISOU 81 CZ ADPN A1004 878 1084 1757 -28 -147 -222 C
HETATM 82 CZ BDPN A1004 4.193 14.092 13.337 0.50 6.42 C
ANISOU 82 CZ BDPN A1004 712 1167 415 181 -136 -4 C
TER 83 DPN A1004
HETATM 84 C MOH A1101 8.666 16.001 20.906 1.00 12.01 C
ANISOU 84 C MOH A1101 1313 1604 1375 234 29 130 C
HETATM 85 O MOH A1101 7.615 15.771 19.731 1.00 14.04 O
ANISOU 85 O MOH A1101 1393 1437 2187 -560 -330 161 O
HETATM 86 O HOH A1201 6.056 16.337 21.416 1.00 35.13 O
ANISOU 86 O HOH A1201 3315 3114 6126 2014 2192 2827 O
HETATM 87 O HOH A1202 5.021 14.179 22.772 0.64 22.61 O
ANISOU 87 O HOH A1202 6471 835 773 641 683 -45 O
HETATM 88 O HOH A1203 1.070 17.633 18.943 1.00 10.30 O
ANISOU 88 O HOH A1203 695 1138 1846 169 181 763 O
HETATM 89 O HOH A1204 0.899 13.588 21.113 1.00 14.38 O
ANISOU 89 O HOH A1204 1417 2449 1271 -722 39 3 O
HETATM 90 O HOH A1205 6.435 13.678 16.151 0.50 9.48 O
ANISOU 90 O HOH A1205 978 1069 1340 8 -3 59 O
HETATM 91 O HOH A1206 6.308 13.206 24.372 1.00 23.73 O
ANISOU 91 O HOH A1206 3977 2288 2214 845 -343 -768 O
HETATM 92 O HOH A1207 8.220 13.250 23.526 0.50 9.31 O
ANISOU 92 O HOH A1207 1032 1094 1202 -15 219 243 O
CONECT 1 3 5
CONECT 2 4 6
CONECT 3 1
CONECT 4 2
CONECT 5 1 7 15
CONECT 6 2 8 16
CONECT 7 5 9
CONECT 8 6 10
CONECT 9 7 11 13
CONECT 10 8 12 14
CONECT 11 9
CONECT 12 10
CONECT 13 9
CONECT 14 10
CONECT 15 5 17 19
CONECT 16 6 18 20
CONECT 17 15
CONECT 18 16
CONECT 19 15
CONECT 20 16
CONECT 23 41
CONECT 24 42
CONECT 41 23 43 45
CONECT 42 24 44 46
CONECT 43 41
CONECT 44 42
CONECT 45 41 47 55
CONECT 46 42 48 56
CONECT 47 45 49
CONECT 48 46 50
CONECT 49 47 51 53
CONECT 50 48 52 54
CONECT 51 49
CONECT 52 50
CONECT 53 49
CONECT 54 50
CONECT 55 45 57 59
CONECT 56 46 58 60
CONECT 57 55
CONECT 58 56
CONECT 59 55 61
CONECT 60 56 62
CONECT 61 59 63 69
CONECT 62 60 64 70
CONECT 63 61 65 67
CONECT 64 62 66 68
CONECT 65 63
CONECT 66 64
CONECT 67 63
CONECT 68 64
CONECT 69 61 71
CONECT 70 62 72
CONECT 71 69 73 75
CONECT 72 70 74 76
CONECT 73 71 77
CONECT 74 72 78
CONECT 75 71 79
CONECT 76 72 80
CONECT 77 73 81
CONECT 78 74 82
CONECT 79 75 81
CONECT 80 76 82
CONECT 81 77 79
CONECT 82 78 80
CONECT 84 85
CONECT 85 84
MASTER 201 0 4 0 0 0 0 6 50 1 66 1
END